THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
The company’s breakthrough IC-8 IOL combines its patented small aperture technology with a state-of-the-art monofocal IOL. This unique design delivers focused light through the small aperture to the retina without interference from peripheral defocused light. The result is clear vision across near, intermediate, and far distances. “At AcuFocus, we provide superior outcomes and consistent satisfaction to both patients and physicians, with our proven and reliable technologies,” states Alan (Al) Waterhouse, the CEO and President of AcuFocus.![]()
At AcuFocus, we provide superior outcomes and consistent satisfaction to both patients and physicians, with our proven and reliable technologies
Share this Article:
Tweet
|
Company
AcuFocus
Headquarters
Irvine, CA
Management
Alan Waterhouse, CEO & President
Description
AcuFocus is a privately-held ophthalmic medical device company aimed at designing and delivering breakthrough technologies for the improvement of vision for cataract patients. Its proprietary technology platform utilizes the small aperture (pinhole) effect to allow focused light rays to reach the retina and provide clear visibility. Its flagship product, the IC-8 IOL is designed specifically for cataract patients and delivers continuous, high quality extended depth of focus free from blurry zones. The IOL protects central organized light by disrupting peripheral defocused light, instead of splitting light like other IOLs, and prevents unintended consequences such as halo or glare and other visual disturbances for patients
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info